Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.

Antimicrobial Agents and Chemotherapy
K P Fu, H C Neu

Abstract

The in vitro activity of ceftizoxime was compared with that of other beta-lactam antibiotics against 538 isolates. Ceftizoxime was the most active agent tested against Escherichia coli and Klebsiella, inhibiting 80% at 0.025 microgram/ml. It was more active than cefotaxime against Enterobacter cloacae and E. aerogenes. Ceftizoxime was more active than cefoxitin, cefotaxime, cefoperazone, and carbenicillin against Proteus mirabilis and indole-positive Proteus. It inhibited 97% of multiresistant Serratia isolates at 12.5 microgram/ml, whereas cefotaxime inhibited only 19%. Ceftizoxime was less active than cefotaxime and cefoperazone against Pseudomonas aeruginosa, but was more active than carbenicillin. It was more active than cefotaxime and cefoxitin against Bacteroides. It was not appreciably destroyed by beta-lactamases of Staphylococcus aureus, Enterobacteriaceae, or Pseudomonas.

References

Aug 1, 1979·Antimicrobial Agents and Chemotherapy·H C NeuK Kung
Apr 1, 1972·Antimicrobial Agents and Chemotherapy·C H O'CallaghanA H Shingler
Aug 1, 1974·Antimicrobial Agents and Chemotherapy·H C Neu

❮ Previous
Next ❯

Citations

Nov 1, 1995·Journal of Clinical Pharmacology·A S RosemurgyM H Albrink
Apr 1, 1983·European Journal of Clinical Microbiology·H LodeP Koeppe
Jun 1, 1984·European Journal of Clinical Microbiology·M Diez EncisoA Gutièrrez Altès
Jun 1, 1982·European Journal of Clinical Microbiology·P C AppelbaumG A Pankuch
Jan 1, 1985·International Urology and Nephrology·M TripiG Carella
Feb 1, 1988·Diagnostic Microbiology and Infectious Disease·C E EdmistonR E Condon
Mar 1, 1981·Antimicrobial Agents and Chemotherapy·H C NeuK P Fu
Apr 1, 1981·Antimicrobial Agents and Chemotherapy·N A KuckM Forbes
Jul 1, 1981·Antimicrobial Agents and Chemotherapy·E YabuuchiA Ohyama
Sep 1, 1981·Antimicrobial Agents and Chemotherapy·H C Neu, S Srinivasan
Nov 1, 1981·Antimicrobial Agents and Chemotherapy·M W Drulak, A W Chow
Dec 1, 1981·Antimicrobial Agents and Chemotherapy·V L Sutter, Y Y Kwok
Jun 1, 1982·Antimicrobial Agents and Chemotherapy·H L Muytjens, J van der Ros-van de Repe
Aug 1, 1982·Antimicrobial Agents and Chemotherapy·M OhkawaK Kuroda
Aug 1, 1983·Antimicrobial Agents and Chemotherapy·E D Burgess, A D Blair
Jun 1, 1984·Antimicrobial Agents and Chemotherapy·R N JonesA L Barry
Oct 1, 1986·Antimicrobial Agents and Chemotherapy·M V BorobioE J Perea
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·S KobayashiK Fujimoto
Oct 1, 1988·Antimicrobial Agents and Chemotherapy·B J Guglielmo, L C Rodondi
Jan 1, 1989·Antimicrobial Agents and Chemotherapy·J E Leggett, W A Craig
Sep 1, 1988·American Journal of Obstetrics and Gynecology·S J FortunatoK F Swan
Feb 25, 1988·The New England Journal of Medicine·G R Donowitz, G L Mandell
Sep 1, 1983·Drug Intelligence & Clinical Pharmacy·P GarzoneV L Yu
Jan 1, 1991·Hospital Practice·R L Nichols, J W Smith
Mar 1, 2011·Analytical Methods : Advancing Methods and Applications·Mir Reza MajidiBehnam Hafezi
Jan 1, 1983·Drug Intelligence & Clinical Pharmacy·J A Lyon
Jan 1, 1984·Infection·M WestenfelderA Frankenschmidt
Aug 28, 2020·The Journal of Organic Chemistry·Anant S BalijepalliMark W Grinstaff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.